Peter Lynch fit · Growth at a reasonable price (GARP)
Is Avanos Medical, Inc. (AVNS) a Peter Lynch Stock?
Does not fit Lynch's GARP criteria - growth too low or price too high.
0/100
FNot a fit
1/6 criteria passed
Peter Lynch's Criteria, Applied to AVNS
PEG ≤ 1.0
key-
EPS CAGR ≥ 15%
key-
Revenue CAGR ≥ 10%
-1.5%
Net margin > 0
-9.7%
How AVNS Scores on Other Strategies
Live Financial Snapshot
Market cap
$1.15B
P/E (TTM)
-
ROIC (TTM)
-6.03%
Gross margin
48.55%
Other Peter Lynch fit reports
Frequently Asked Questions
What is AVNS's Peter Lynch fit score?
AVNS scores 0/100 on our Peter Lynch fit engine - grade F. Does not fit Lynch's GARP criteria - growth too low or price too high.
Does Peter Lynch actually own AVNS?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends AVNS.
How often is this score updated?
AVNS's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Peter Lynch personally owns or recommends AVNS.